Gitte aabo biography of martin

She joined LEO Pharma by chance, more than 27 years ago, but she remained there, for the true focus on helping patients and her love of the job.

For more than a century Denmark’s LEO Pharma has had a solid niche, creating and selling drugs for dermatological and thrombotic conditions, penetrating markets across the world.

Its successful portfolio of prescription drugs already treat dozens of chronic and painful maladies.

The unmet needs are big

Now a decade into its second century, LEO Pharma’s  President and CEO Gitte Aabo’s goals for the company seek to strengthen and expand that niche; seeing the firm reach 125 million patients by 2025 and to be a global leader in medical dermatology are among her immediate priorities, but she sees so much more that LEO can do.

“With more than 3 000 recognized skin diseases, the unmet needs are big,” she says.

Her first goals are well on the way to being achieved, considering the compa